Abstract
Gross extraction yield alone cannot establish specification-conforming output, benchmark-equivalent service, or environmental improvement when laboratory findings are extrapolated to industrial configurations. This critical integrative review evaluates evidence needed to translate laboratory results into defensible route-level claims for plant-derived bioproduct valorization. Drawing on agri-food byproduct routes and other plant-derived systems, it synthesizes seven evidence streams: feedstock identity, recovery and profiling, downstream processing, product readiness, circularity and substitution, techno-economic assessment (TEA), and life cycle assessment (LCA). Specification-adjusted route accounting was applied to 17 author-curated packages comprising 45 nested analytical units. Four cases illustrate route misalignment: cumulative artemisinin retention declined from 90.0% after maceration to 37.3% after crystallization; ultrasound-assisted grapefruit pectin extraction increased yield without consistently improving properties; red grape pomace route preference switched within a USD 249–250 kg−1 price interval; and deterministic and probabilistic analyses favored different microencapsulated pomegranate peel extract powder cases. An LCA package identified freeze-drying as a hotspot but did not establish comparative environmental improvement. Across 170 package–field decisions, specification and service-equivalence gaps constrained conclusions, and no package provided verifiable observed-displacement evidence. The framework identifies the first unsupported link to close before stronger route-level claims are warranted. The case set is nonrepresentative; independent prospective evaluation is required.
All Related Versions

This publication has 61 references indexed in Scilit: